Ocular Hypertension Treatment Global Market Report 2025

Published Feb 28, 2025

Length 200 Pages

SKU # BRC19654341

Description

Ocular Hypertension Treatment Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on ocular hypertension treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Description:

Where is the largest and fastest growing market for ocular hypertension treatment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The ocular hypertension treatment market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:1) By Type: Intraocular Hypertension; Glaucoma

2) By Route of Administration: Oral; Parenteral; Other Routes

3) By Distribution Channel: Hospital Pharmacy; Retail Pharmacy; Online Pharmacy; Other Distribution Channel

4) By End-Users: Hospitals; Specialty Clinics; Other End-Users

Subsegments:

1) By Intraocular Hypertension: Beta Blockers; Prostaglandin Analogs; Carbonic Anhydrase Inhibitors; Alpha Agonists; Rho Kinase Inhibitors

2) By Glaucoma: Open-Angle Glaucoma Treatments; Angle-Closure Glaucoma Treatments; Secondary Glaucoma Treatments; Congenital Glaucoma Treatments; Combination Therapies

Companies Mentioned: Angelini SpA; Laboratorios Sophia; Neurim Pharmaceuticals Ltd.; Nicox SA; Novartis AG

Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,

Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Delivery format: PDF, Word and Excel Data Dashboard.

Please Note: Report will be updated with the latest data and delivered to you within 3-5 working days of order.

1. Executive Summary
2. Ocular Hypertension Treatment Market Characteristics
3. Ocular Hypertension Treatment Market Trends And Strategies
4. Ocular Hypertension Treatment Market - Macro Economic Scenario including the impact of Interest Rates, Inflation, Geopolitics and Covid And Recovery on the Market
5. Global Ocular Hypertension Treatment Growth Analysis And Strategic Analysis Framework: 5.1. Global Ocular Hypertension Treatment PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints); 5.2. Analysis Of End Use Industries; 5.3. Global Ocular Hypertension Treatment Market Growth Rate Analysis; 5.4. Global Ocular Hypertension Treatment Historic Market Size and Growth, 2019 - 2024, Value ($ Billion); 5.5. Global Ocular Hypertension Treatment Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion); 5.6. Global Ocular Hypertension Treatment Total Addressable Market (TAM)
6. Ocular Hypertension Treatment Market Segmentation: 6.1. Global Ocular Hypertension Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; Intraocular Hypertension; Glaucoma; 6.2. Global Ocular Hypertension Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; Oral; Parenteral; Other Routes; 6.3. Global Ocular Hypertension Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; Hospital Pharmacy; Retail Pharmacy; Online Pharmacy; Other Distribution Channel; 6.4. Global Ocular Hypertension Treatment Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; Hospitals; Specialty Clinics; Others End-Users; 6.5. Global Ocular Hypertension Treatment Market, Sub-Segmentation Of Intraocular Hypertension, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; Beta Blockers; Prostaglandin Analogs; Carbonic Anhydrase Inhibitors; Alpha Agonists; Rho Kinase Inhibitors; 6.6. Global Ocular Hypertension Treatment Market, Sub-Segmentation Of Glaucoma, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; Open-Angle Glaucoma Treatments; Angle-Closure Glaucoma Treatments; Secondary Glaucoma Treatments; Congenital Glaucoma Treatments; Combination Therapies
7. Ocular Hypertension Treatment Market Regional And Country Analysis: 7.1. Global Ocular Hypertension Treatment Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 7.2. Global Ocular Hypertension Treatment Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8. Asia-Pacific Ocular Hypertension Treatment Market: 8.1. Asia-Pacific Ocular Hypertension Treatment Market Overview; Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies; 8.2. Asia-Pacific Ocular Hypertension Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 8.3. Asia-Pacific Ocular Hypertension Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 8.4. Asia-Pacific Ocular Hypertension Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Ocular Hypertension Treatment Market: 9.1. China Ocular Hypertension Treatment Market Overview; 9.2. China Ocular Hypertension Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion; 9.3. China Ocular Hypertension Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion; 9.4. China Ocular Hypertension Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Ocular Hypertension Treatment Market: 10.1. India Ocular Hypertension Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 10.2. India Ocular Hypertension Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 10.3. India Ocular Hypertension Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Ocular Hypertension Treatment Market: 11.1. Japan Ocular Hypertension Treatment Market Overview; 11.2. Japan Ocular Hypertension Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 11.3. Japan Ocular Hypertension Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 11.4. Japan Ocular Hypertension Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Ocular Hypertension Treatment Market: 12.1. Australia Ocular Hypertension Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 12.2. Australia Ocular Hypertension Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 12.3. Australia Ocular Hypertension Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Ocular Hypertension Treatment Market: 13.1. Indonesia Ocular Hypertension Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 13.2. Indonesia Ocular Hypertension Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 13.3. Indonesia Ocular Hypertension Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Ocular Hypertension Treatment Market: 14.1. South Korea Ocular Hypertension Treatment Market Overview; 14.2. South Korea Ocular Hypertension Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 14.3. South Korea Ocular Hypertension Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 14.4. South Korea Ocular Hypertension Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Ocular Hypertension Treatment Market: 15.1. Western Europe Ocular Hypertension Treatment Market Overview; 15.2. Western Europe Ocular Hypertension Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 15.3. Western Europe Ocular Hypertension Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 15.4. Western Europe Ocular Hypertension Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Ocular Hypertension Treatment Market: 16.1. UK Ocular Hypertension Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 16.2. UK Ocular Hypertension Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 16.3. UK Ocular Hypertension Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Ocular Hypertension Treatment Market: 17.1. Germany Ocular Hypertension Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 17.2. Germany Ocular Hypertension Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 17.3. Germany Ocular Hypertension Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Ocular Hypertension Treatment Market: 18.1. France Ocular Hypertension Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 18.2. France Ocular Hypertension Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 18.3. France Ocular Hypertension Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Ocular Hypertension Treatment Market: 19.1. Italy Ocular Hypertension Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 19.2. Italy Ocular Hypertension Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 19.3. Italy Ocular Hypertension Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Ocular Hypertension Treatment Market: 20.1. Spain Ocular Hypertension Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 20.2. Spain Ocular Hypertension Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 20.3. Spain Ocular Hypertension Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Ocular Hypertension Treatment Market: 21.1. Eastern Europe Ocular Hypertension Treatment Market Overview; 21.2. Eastern Europe Ocular Hypertension Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 21.3. Eastern Europe Ocular Hypertension Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 21.4. Eastern Europe Ocular Hypertension Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Ocular Hypertension Treatment Market: 22.1. Russia Ocular Hypertension Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 22.2. Russia Ocular Hypertension Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 22.3. Russia Ocular Hypertension Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Ocular Hypertension Treatment Market: 23.1. North America Ocular Hypertension Treatment Market Overview; 23.2. North America Ocular Hypertension Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 23.3. North America Ocular Hypertension Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 23.4. North America Ocular Hypertension Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Ocular Hypertension Treatment Market: 24.1. USA Ocular Hypertension Treatment Market Overview; 24.2. USA Ocular Hypertension Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 24.3. USA Ocular Hypertension Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 24.4. USA Ocular Hypertension Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25. Canada Ocular Hypertension Treatment Market: 25.1. Canada Ocular Hypertension Treatment Market Overview; 25.2. Canada Ocular Hypertension Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 25.3. Canada Ocular Hypertension Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 25.4. Canada Ocular Hypertension Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Ocular Hypertension Treatment Market: 26.1. South America Ocular Hypertension Treatment Market Overview; 26.2. South America Ocular Hypertension Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 26.3. South America Ocular Hypertension Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 26.4. South America Ocular Hypertension Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Ocular Hypertension Treatment Market: 27.1. Brazil Ocular Hypertension Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 27.2. Brazil Ocular Hypertension Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 27.3. Brazil Ocular Hypertension Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Ocular Hypertension Treatment Market: 28.1. Middle East Ocular Hypertension Treatment Market Overview; 28.2. Middle East Ocular Hypertension Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 28.3. Middle East Ocular Hypertension Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 28.4. Middle East Ocular Hypertension Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Ocular Hypertension Treatment Market: 29.1. Africa Ocular Hypertension Treatment Market Overview; 29.2. Africa Ocular Hypertension Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 29.3. Africa Ocular Hypertension Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 29.4. Africa Ocular Hypertension Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Ocular Hypertension Treatment Market Competitive Landscape And Company Profiles: 30.1. Ocular Hypertension Treatment Market Competitive Landscape; 30.2. Ocular Hypertension Treatment Market Company Profiles; 30.2.1. Angelini SpA Overview, Products and Services, Strategy and Financial Analysis; 30.2.2. Laboratorios Sophia Overview, Products and Services, Strategy and Financial Analysis; 30.2.3. Neurim Pharmaceuticals Ltd. Overview, Products and Services, Strategy and Financial Analysis; 30.2.4. Nicox SA Overview, Products and Services, Strategy and Financial Analysis; 30.2.5. Novartis AG Overview, Products and Services, Strategy and Financial Analysis
31. Ocular Hypertension Treatment Market Other Major And Innovative Companies: 31.1. AbbVie Inc.; 31.2. Alcon; 31.3. Ocular Therapeutix Inc.; 31.4. Sylentis S.A; 31.5. Taejoon Pharma Co. Ltd.; 31.6. Bausch Health Companies Inc.; 31.7. Merck & Co. Inc.; 31.8. Pfizer Inc.; 31.9. Teva Pharmaceutical Industries Ltd.; 31.10. Laboratorios Salvat SA; 31.11. Shionogi & Co. Ltd.; 31.12. Otsuka Holdings Co. Ltd.; 31.13. Mitsubishi Tanabe Pharma Corporation; 31.14. Astellas Pharma Inc.; 31.15. Eisai Co. Ltd.
32. Global Ocular Hypertension Treatment Market Competitive Benchmarking And Dashboard
33. Key Mergers And Acquisitions In The Ocular Hypertension Treatment Market
34. Recent Developments In The Ocular Hypertension Treatment Market
35. Ocular Hypertension Treatment Market High Potential Countries, Segments and Strategies: 35.1 Ocular Hypertension Treatment Market In 2029 - Countries Offering Most New Opportunities; 35.2 Ocular Hypertension Treatment Market In 2029 - Segments Offering Most New Opportunities; 35.3 Ocular Hypertension Treatment Market In 2029 - Growth Strategies; 35.3.1 Market Trend Based Strategies; 35.3.2 Competitor Strategies
36. Appendix: 36.1. Abbreviations; 36.2. Currencies; 36.3. Historic And Forecast Inflation Rates; 36.4. Research Inquiries; 36.5. The Business Research Company; 36.6. Copyright And Disclaimer

Pricing

Currency Rates

Single User Email from Publisher $4,490
Site License Fulfilled by Publisher $6,490
Global Site License Email from Publisher $8,490

How Do Licenses Work?

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.

Chat Now